Sidley Advises Star51 Capital on UltraSight's US$24 Million Financing

Sidley Austin has represented Star51 Capital in its investment in UltraSight's US$24 million financing, according to an announcement reported by Legal Desire.

The US$24 million round provides fresh capital for UltraSight, a company developing artificial intelligence technology designed to guide ultrasound examinations. Sidley acted as legal counsel to Star51 Capital, one of the investors participating in the financing.

The transaction underscores the continued flow of institutional capital into medical imaging and AI-assisted diagnostics. For Star51 Capital, the investment adds a healthcare technology position to its portfolio. For Sidley, the mandate extends the firm's private equity and venture investment practice, which regularly handles financing work for growth-stage companies.

UltraSight has positioned its technology as a tool for improving the accuracy and accessibility of ultrasound procedures, targeting a market where operator skill has traditionally been a limiting factor. The new capital is expected to support the company's continued product development and commercial expansion.

The deal adds to a broader pattern of investor interest in AI-enabled diagnostic platforms, where funding has remained resilient even as broader venture markets have tightened. The involvement of established investors such as Star51 Capital, with Sidley advising on the transaction, signals institutional confidence in the segment.

The financing is expected to accelerate UltraSight's push into additional clinical settings and markets.